4/A: Proto Labs COO Amends Stock Option Expiration Date

Proto Labs' Chief Operations Officer, Michael R. Kenison, filed an amended Form 4 to correct a clerical error regarding the expiration date of employee stock options, while also reporting recent stock transactions.

Summary

• An amendment to a previously filed Form 4 was submitted by Michael R. Kenison, Chief Operations Officer of Proto Labs Inc. (PRLB).
• The amendment corrects a clerical error in the expiration date of employee stock options, changing it to February 14, 2026.
• On November 25, 2025, Mr. Kenison exercised 3,048 employee stock options at an exercise price of $33.84 per share.
• Concurrently, on November 25, 2025, he sold 3,048 shares of common stock at a weighted average price of $50.1741 per share, with individual sale prices ranging from $50.00 to $50.53.
• These transactions were executed pursuant to a Rule 10b5-1 plan adopted on August 15, 2025.
• Following these transactions, Mr. Kenison beneficially owns 28,898 shares of Proto Labs common stock.
• The reported beneficial ownership includes 57 shares of common stock purchased on November 15, 2025, through the issuer's Employee Stock Purchase Plan program.

Sentiment

Score: 5

Explanation: Neutral. The filing reports a routine insider transaction and a clerical correction, neither of which inherently indicates positive or negative sentiment for the company's operational or financial performance.

Positives

• The Chief Operations Officer realized a profit from exercising stock options and selling shares, indicating a personal financial gain.
• The transactions were conducted under a pre-arranged 10b5-1 plan, which provides transparency and helps mitigate concerns about opportunistic insider trading.

Future Outlook

N/A

Management Comments

• The filing details stock transactions by Chief Operations Officer Michael R. Kenison, including the exercise of employee stock options and subsequent sale of shares, executed under a Rule 10b5-1 plan.

Industry Context

N/A

Stakeholder Impact

• Shareholders: Provides transparency on insider stock transactions, demonstrating an officer's exercise of options and subsequent sale of shares.
• Employees: Illustrates the use of employee stock plans by a senior officer.

Key Dates

Recommendation

This Form 4/A primarily reports a routine insider stock transaction by the Chief Operations Officer, executed under a pre-planned 10b5-1 program, and corrects a clerical error in a previous filing. It does not contain new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The sale of shares by an officer under a 10b5-1 plan is a common practice and does not necessarily indicate a lack of confidence in the company's future.

Keywords

Proto Labs, PRLB, Form 4/A, Insider Trading, Stock Options, 10b5-1 Plan, Officer Transactions, Michael R. Kenison, Beneficial Ownership